OS Therapies Incorporated
OSTX
$1.79
$0.084.68%
AMEX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -28.75M | -18.28M | -14.28M | -11.30M | -8.88M |
| Total Depreciation and Amortization | 363.00K | 239.50K | 114.60K | 2.80K | 2.80K |
| Total Amortization of Deferred Charges | 1.04M | 0.00 | 338.30K | 1.43M | 1.43M |
| Total Other Non-Cash Items | 4.01M | 2.70M | 1.65M | 456.60K | 301.80K |
| Change in Net Operating Assets | 9.11M | 2.46M | 616.90K | -666.90K | -129.80K |
| Cash from Operations | -14.24M | -12.88M | -11.56M | -10.08M | -7.28M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -466.40K | -466.40K | -466.40K | -173.60K | -- |
| Cash from Investing | -466.40K | -466.40K | -466.40K | -173.60K | -- |
| Total Debt Issued | -- | 0.00 | 0.00 | 900.00K | 1.75M |
| Total Debt Repaid | -- | 0.00 | -250.00K | -250.00K | -250.00K |
| Issuance of Common Stock | 7.86M | 6.26M | 5.23M | 5.23M | 5.23M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 1.05M | 7.10M | 7.10M | 7.10M | 6.05M |
| Repurchase of Preferred Stock | -600.00 | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 530.20K | 0.00 | 2.66M | 148.00K | 0.00 |
| Cash from Financing | 9.44M | 13.37M | 14.74M | 13.13M | 12.78M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5.26M | 18.50K | 2.71M | 2.87M | 5.49M |